Laffer Tengler Investments’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-265
| Closed | -$32.4K | – | 411 |
|
|
2023
Q2 | $32.4K | Sell |
265
-28,068
| -99% | -$3.43M | 0.01% | 335 |
|
|
2023
Q1 | $3.42M | Sell |
28,333
-75
| -0.3% | -$9.04K | 0.93% | 33 |
|
|
2022
Q4 | $3.26M | Sell |
28,408
-1,239
| -4% | -$142K | 0.94% | 36 |
|
|
2022
Q3 | $3.03M | Sell |
29,647
-1,040
| -3% | -$106K | 1.11% | 21 |
|
|
2022
Q2 | $3.12M | Buy |
30,687
+38
| +0.1% | +$3.87K | 1.1% | 22 |
|
|
2022
Q1 | $3.57M | Buy |
30,649
+142
| +0.5% | +$16.6K | 1.08% | 18 |
|
|
2021
Q4 | $3.49M | Sell |
30,507
-238
| -0.8% | -$27.2K | 1.01% | 22 |
|
|
2021
Q3 | $3.58M | Sell |
30,745
-613
| -2% | -$71.3K | 1.03% | 20 |
|
|
2021
Q2 | $3.62M | Buy |
31,358
+5,223
| +20% | +$604K | 1.36% | 13 |
|
|
2021
Q1 | $2.82M | Sell |
26,135
-948
| -4% | -$102K | 1.07% | 34 |
|
|
2020
Q4 | $2.95M | Buy |
27,083
+6,136
| +29% | +$669K | 1.25% | 25 |
|
|
2020
Q3 | $2.34M | Buy |
20,947
+752
| +4% | +$83.9K | 1.17% | 33 |
|
|
2020
Q2 | $2.11M | Buy |
+20,195
| New | +$2.11M | 1.21% | 35 |
|